Does Cup Position at the High Hip Center or Anatomic Hip Center in THA for Developmental Dysplasia of the Hip Result in Better Harris Hip Scores and Revision Incidence? A Systematic Review.


Journal

Clinical orthopaedics and related research
ISSN: 1528-1132
Titre abrégé: Clin Orthop Relat Res
Pays: United States
ID NLM: 0075674

Informations de publication

Date de publication:
01 05 2021
Historique:
received: 31 05 2020
accepted: 03 12 2020
pubmed: 5 2 2021
medline: 21 9 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

One goal of THA is to restore the anatomic hip center, which can be achieved in hips with developmental dysplasia by placing cups at the level of the native acetabulum. However, this might require adjuvant procedures such as femoral shortening osteotomy. Another option is to place the cup at the high hip center, potentially reducing surgical complexity. Currently, no clear consensus exists regarding which of these cup positions might offer better functional outcomes or long-term survival. We performed a systematic review to determine whether (1) functional outcomes as measured by the Harris hip score, (2) revision incidence, and (3) complications that do not result in revision differ based on the position of the acetabular cup (high hip center versus anatomic hip center) in patients undergoing THA for developmental dysplasia of the hip (DDH). We performed a systematic review using Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines, including studies comparing the functional outcomes, revision incidence, and complications of primary THA in dysplastic hips with acetabular cups placed at the high hip center versus those placed at the anatomic hip center, over any time frame. The review protocol was registered with PROSPERO (registration number CRD42020168183) before commencement. Of 238 records, eight comparative, retrospective nonrandomized studies of interventions were eligible for our systematic review, reporting on 207 hips with cups placed at the high hip center and 268 hips with cups at the anatomic hip center. Risk of bias within eligible studies was assessed using the Risk Of Bias In Non-randomized Studies of Interventions tool. Due to low comparability between studies, data could not be pooled, so these studies were assessed without summary effects. Six studies compared Harris hip scores, two of which favored high hip center cup placement and three of which favored anatomic hip center cup placement, although none of the differences between cohorts met the minimum clinically important difference. Five studies reliably compared revision incidence, which ranged from 2% to 9% for high hip center at 7 to 15 years and 0% to 5.9% for anatomic hip center at 6 to 16 years. Five studies reported intra- and postoperative complications, with the high hip center being associated with higher incidence of dislocation and lower incidence of neurological complications. No clear difference was observed in intraoperative complications between the high hip center and anatomic hip center. No obvious differences could be observed in Harris hip score or revision incidence after THA for osteoarthritis secondary to DDH between cups placed at the anatomic hip center and those placed at the high hip center. Placement of the acetabular cup in the high hip center may lead to higher risk of dislocation but lower risk of neurologic complications, although no difference in intraoperative complications was observed. Surgeons should be able to achieve satisfactory functional scores and revision incidence using either technique, although they should be aware of how their choice influences hip biomechanics and the need for adjunct procedures and associated risks and operative time. These recommendations should be considered with respect to the several limitations in the studies reviewed, including the presence of serious confounding factors and selection biases, inconsistent definitions of the high hip center, variations in dysplasia severity, small sample sizes, and follow-up periods. These weaknesses should be addressed in well-designed future studies. Level III, therapeutic study.

Sections du résumé

BACKGROUND
One goal of THA is to restore the anatomic hip center, which can be achieved in hips with developmental dysplasia by placing cups at the level of the native acetabulum. However, this might require adjuvant procedures such as femoral shortening osteotomy. Another option is to place the cup at the high hip center, potentially reducing surgical complexity. Currently, no clear consensus exists regarding which of these cup positions might offer better functional outcomes or long-term survival.
QUESTION/PURPOSE
We performed a systematic review to determine whether (1) functional outcomes as measured by the Harris hip score, (2) revision incidence, and (3) complications that do not result in revision differ based on the position of the acetabular cup (high hip center versus anatomic hip center) in patients undergoing THA for developmental dysplasia of the hip (DDH).
METHODS
We performed a systematic review using Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines, including studies comparing the functional outcomes, revision incidence, and complications of primary THA in dysplastic hips with acetabular cups placed at the high hip center versus those placed at the anatomic hip center, over any time frame. The review protocol was registered with PROSPERO (registration number CRD42020168183) before commencement. Of 238 records, eight comparative, retrospective nonrandomized studies of interventions were eligible for our systematic review, reporting on 207 hips with cups placed at the high hip center and 268 hips with cups at the anatomic hip center. Risk of bias within eligible studies was assessed using the Risk Of Bias In Non-randomized Studies of Interventions tool. Due to low comparability between studies, data could not be pooled, so these studies were assessed without summary effects.
RESULTS
Six studies compared Harris hip scores, two of which favored high hip center cup placement and three of which favored anatomic hip center cup placement, although none of the differences between cohorts met the minimum clinically important difference. Five studies reliably compared revision incidence, which ranged from 2% to 9% for high hip center at 7 to 15 years and 0% to 5.9% for anatomic hip center at 6 to 16 years. Five studies reported intra- and postoperative complications, with the high hip center being associated with higher incidence of dislocation and lower incidence of neurological complications. No clear difference was observed in intraoperative complications between the high hip center and anatomic hip center.
CONCLUSION
No obvious differences could be observed in Harris hip score or revision incidence after THA for osteoarthritis secondary to DDH between cups placed at the anatomic hip center and those placed at the high hip center. Placement of the acetabular cup in the high hip center may lead to higher risk of dislocation but lower risk of neurologic complications, although no difference in intraoperative complications was observed. Surgeons should be able to achieve satisfactory functional scores and revision incidence using either technique, although they should be aware of how their choice influences hip biomechanics and the need for adjunct procedures and associated risks and operative time. These recommendations should be considered with respect to the several limitations in the studies reviewed, including the presence of serious confounding factors and selection biases, inconsistent definitions of the high hip center, variations in dysplasia severity, small sample sizes, and follow-up periods. These weaknesses should be addressed in well-designed future studies.
LEVEL OF EVIDENCE
Level III, therapeutic study.

Identifiants

pubmed: 33539054
pii: 00003086-202105000-00040
doi: 10.1097/CORR.0000000000001618
pmc: PMC8051996
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1119-1130

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 by the Association of Bone and Joint Surgeons.

Déclaration de conflit d'intérêts

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

Références

Argenson JN, Flecher X, Parratte S, Aubaniac JM. Anatomy of the dysplastic hip and consequences for total hip arthroplasty. Clin Orthop Relat Res. 2007;465:40-45.
Bicanic G, Delimar D, Delimar M, Pecina M. Influence of the acetabular cup position on hip load during arthroplasty in hip dysplasia. Int Orthop. 2009;33:397-402.
Chen M, Luo ZL, Wu KR, Zhang XQ, Ling XD, Shang XF. Cementless total hip arthroplasty with a high hip center for Hartofilakidis type B developmental dysplasia of the hip: results of midterm follow-up. J Arthroplasty. 2016;31:1027-1034.
Christodoulou NA, Dialetis KP, Christodoulou AN. High hip center technique using a biconical threaded Zweymuller cup in osteoarthritis secondary to congenital hip disease. Clin Orthop Relat Res. 2010;468:1912-1919.
Dapuzzo MR, Sierra RJ. Acetabular considerations during total hip arthroplasty for hip dysplasia. Orthop Clin North Am. 2012;43:369-375.
Faber T, Ravaud P, Riveros C, Perrodeau E, Dechartres A. Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review. BMC Med Res Methodol. 2016;16:35.
Flecher X, Parratte S, Brassart N, Aubaniac JM, Argenson JN. Evaluation of the hip center in total hip arthroplasty for old developmental dysplasia. J Arthroplasty. 2008;23:1189-1196.
Fukui K, Kaneuji A, Sugimori T, Ichiseki T, Matsumoto T. How far above the true anatomic position can the acetabular cup be placed in total hip arthroplasty? Hip Int. 2013;23:129-134.
Fukushi JI, Kawano I, Motomura G, Hamai S, Kawaguchi KI, Nakashima Y. Does hip center location affect the recovery of abductor moment after total hip arthroplasty? Orthop Traumatol Surg Res. 2018;104:1149-1153.
Georgiades G, Babis GC, Kourlaba G, Hartofilakidis G. Effect of cementless acetabular component orientation, position, and containment in total hip arthroplasty for congenital hip disease. J Arthroplasty. 2010;25:1143-1150.
Higgins JP, Altman DG, Gotzsche PC. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Hirakawa K, Mitsugi N, Koshino T, Saito T, Hirasawa Y, Kubo T. Effect of acetabular cup position and orientation in cemented total hip arthroplasty. Clin Orthop Relat Res. 2001;388:135-142.
Ito H, Matsuno T, Minami A, Aoki Y. Intermediate-term results after hybrid total hip arthroplasty for the treatment of dysplastic hips. J Bone Joint Surg Am. 2003;85:1725-1732.
Kaneuji A, Sugimori T, Ichiseki T, Yamada K, Fukui K, Matsumoto T. Minimum ten-year results of a porous acetabular component for Crowe I to III hip dysplasia using an elevated hip center. J Arthroplasty. 2009;24:187-194.
Karaismailoglu B, Erdogan F, Kaynak G. High hip center reduces the dynamic hip range of motion and increases the hip load: a gait analysis study in hip arthroplasty patients with unilateral developmental dysplasia. J Arthroplasty. 2019;34:1267-1272.e1.
Karaismailoglu B, Kaynak G, Can A, Ozsahin MK, Erdogan F. Bilateral high hip center provides gait parameters similar to anatomical reconstruction: a gait analysis study in hip replacement patients with bilateral developmental dysplasia. J Arthroplasty. 2019;34:3099-3105.
Kobayashi S, Saito N, Nawata M, Horiuchi H, Iorio R, Takaoka K. Total hip arthroplasty with bulk femoral head autograft for acetabular reconstruction in developmental dysplasia of the hip. J Bone Joint Surg Am. 2003;85:615-621.
Komiyama K, Fukushi JI, Motomura G. Does high hip centre affect dislocation after total hip arthroplasty for developmental dysplasia of the hip? Int Orthop. 2019;43:2057-2063.
Marangoz S, Atilla B, Gok H. Gait analysis in adults with severe hip dysplasia before and after total hip arthroplasty. Hip Int. 2010;20:466-472.
McInnes MDF, Moher D, Thombs BD. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319:388-396.
Montalti M, Castagnini F, Giardina F, Tassinari E, Biondi F, Toni A. Cementless total hip arthroplasty in Crowe III and IV dysplasia: high hip center and modular necks. J Arthroplasty. 2018;33:1813-1819.
Murayama T, Ohnishi H, Okabe S. 15-year comparison of cementless total hip arthroplasty with anatomical or high cup placement for Crowe I to III hip dysplasia. Orthopedics. 2012;35:e313-318.
Nawabi DH, Meftah M, Nam D, Ranawat AS, Ranawat CS. Durable fixation achieved with medialized, high hip center cementless THAs for Crowe II and III dysplasia. Clin Orthop Relat Res. 2014;472:630-636.
Nie Y, Ning N, Pei F, Shen B, Zhou Z, Li Z. Gait kinematic deviations in patients with developmental dysplasia of the hip treated with total hip arthroplasty. Orthopedics. 2017;40:e425-e431.
Ollivier M, Abdel MP, Krych AJ, Trousdale RT, Berry DJ. Long-term results of total hip arthroplasty with shortening subtrochanteric osteotomy in Crowe IV developmental dysplasia. J Arthroplasty. 2016;31:1756-1760.
Ozden VE, Dikmen G, Beksac B, Tozun IR. Long-term retrospective study on the placement of the cementless acetabular cup and clinical outcomes in patients undergoing femoral head autografting for hip dysplasia and total hip arthroplasty. J Orthop Sci. 2018;23:525-531.
Ranawat CS, Dorr LD, Inglis AE. Total hip arthroplasty in protrusio acetabuli of rheumatoid arthritis. J Bone Joint Surg Am. 1980;62:1059-1065.
Russotti GM, Harris WH. Proximal placement of the acetabular component in total hip arthroplasty. A long-term follow-up study. J Bone Joint Surg Am. 1991;73:587-592.
Schutzer SF, Harris WH. High placement of porous-coated acetabular components in complex total hip arthroplasty. J Arthroplasty. 1994;9:359-367.
Sofu H, Ahin VS, Gursu S, Yildirim T, Issin A, Kockara N. Cementless total hip arthroplasty in patients with Crowe type-4 developmental dysplasia. Hip Int. 2013;23:472-477.
Song JH, Ahn TS, Yoon PW, Chang JS. Reliability of the acetabular reconstruction technique using autogenous bone graft from resected femoral head in hip dysplasia: influence of the change of hip joint center on clinical outcome. J Orthop. 2017;14:438-444.
Stans AA, Pagnano MW, Shaughnessy WJ, Hanssen AD. Results of total hip arthroplasty for Crowe Type III developmental hip dysplasia. Clin Orthop Relat Res. 1998;348:149-157.
Sterne JA, Hernan MA, Reeves BC. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Terwey B, Schroder J. Pharmaco-angiography of an eosinophilic renal adenoma [in German]. Rofo. 1977;127:383-384.
Traina F, De Fine M, Biondi F, Tassinari E, Galvani A, Toni A. The influence of the centre of rotation on implant survival using a modular stem hip prosthesis. Int Orthop. 2009;33:1513-1518.
Wamper KE, Sierevelt IN, Poolman RW, Bhandari M, Haverkamp D. The Harris hip score: do ceiling effects limit its usefulness in orthopedics? Acta Orthop. 2010;81:703-707.
Watts CD, Abdel MP, Hanssen AD, Pagnano MW. Anatomic hip center decreases aseptic loosening rates after total hip arthroplasty with cement in patients with Crowe Type-II dysplasia: a concise follow-up report at a mean of thirty-six years. J Bone Joint Surg Am. 2016;98:910-915.
Watts CD, Martin JR, Fehring KA, Griffin WL. Inferomedial hip center decreases failure rates in cementless total hip arthroplasty for Crowe II and III hip dysplasia. J Arthroplasty. 2018;33:2177-2181.
Yang TC, Chen CF, Tsai SW, Chen WM, Chang MC. Does restoration of hip center with subtrochanteric osteotomy provide preferable outcome for Crowe type III-IV irreducible development dysplasia of the hip?? J Chin Med Assoc. 2017;80:803-807.

Auteurs

Patrick Stirling (P)

P. Stirling, L. Strom, M. Saffarini, L. Nover, ReSurg SA, Nyon, Switzerland.
P. Stirling, ReSurg UK, Herefordshire, UK.
M.-R. Viamont-Guerra, F. Laude, Ramsay Santé, Clinique du Sport Paris V, Paris, France.
M.-R. Viamont-Guerra, Hip Surgery Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
A. F. Chen, Department of Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Maria-Roxana Viamont-Guerra (MR)

P. Stirling, L. Strom, M. Saffarini, L. Nover, ReSurg SA, Nyon, Switzerland.
P. Stirling, ReSurg UK, Herefordshire, UK.
M.-R. Viamont-Guerra, F. Laude, Ramsay Santé, Clinique du Sport Paris V, Paris, France.
M.-R. Viamont-Guerra, Hip Surgery Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
A. F. Chen, Department of Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Louise Strom (L)

P. Stirling, L. Strom, M. Saffarini, L. Nover, ReSurg SA, Nyon, Switzerland.
P. Stirling, ReSurg UK, Herefordshire, UK.
M.-R. Viamont-Guerra, F. Laude, Ramsay Santé, Clinique du Sport Paris V, Paris, France.
M.-R. Viamont-Guerra, Hip Surgery Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
A. F. Chen, Department of Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Antonia F Chen (AF)

P. Stirling, L. Strom, M. Saffarini, L. Nover, ReSurg SA, Nyon, Switzerland.
P. Stirling, ReSurg UK, Herefordshire, UK.
M.-R. Viamont-Guerra, F. Laude, Ramsay Santé, Clinique du Sport Paris V, Paris, France.
M.-R. Viamont-Guerra, Hip Surgery Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
A. F. Chen, Department of Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Mo Saffarini (M)

P. Stirling, L. Strom, M. Saffarini, L. Nover, ReSurg SA, Nyon, Switzerland.
P. Stirling, ReSurg UK, Herefordshire, UK.
M.-R. Viamont-Guerra, F. Laude, Ramsay Santé, Clinique du Sport Paris V, Paris, France.
M.-R. Viamont-Guerra, Hip Surgery Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
A. F. Chen, Department of Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Luca Nover (L)

P. Stirling, L. Strom, M. Saffarini, L. Nover, ReSurg SA, Nyon, Switzerland.
P. Stirling, ReSurg UK, Herefordshire, UK.
M.-R. Viamont-Guerra, F. Laude, Ramsay Santé, Clinique du Sport Paris V, Paris, France.
M.-R. Viamont-Guerra, Hip Surgery Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
A. F. Chen, Department of Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Frederic Laude (F)

P. Stirling, L. Strom, M. Saffarini, L. Nover, ReSurg SA, Nyon, Switzerland.
P. Stirling, ReSurg UK, Herefordshire, UK.
M.-R. Viamont-Guerra, F. Laude, Ramsay Santé, Clinique du Sport Paris V, Paris, France.
M.-R. Viamont-Guerra, Hip Surgery Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
A. F. Chen, Department of Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH